Health care stocks were flat to lower premarket Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was recently down 0.3%.
ImmunoPrecise Antibodies (IPA) shares rallied past 14% after the company announced a strategic partnership with an unnamed biotechnology company to discover and develop antibody-drug conjugates and bispecific antibodies to treat cancer.
Integer Holdings (ITGR) shares were down nearly 2% amid plans to offer $750 million of convertible notes due 2030.
Tarsus Pharmaceuticals (TARS) shares were almost 3% lower after the company priced an upsized underwritten public offering of 2.8 million shares at $44.50 per share for gross proceeds of about $125 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.